Skip to main content

Table 3 Summary of multivariate analysis.

From: Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer

Relapse-free survival
Variable Hazard Ratio 95% CI p value
Tumor size (mm) 1.031 [1.005-1.056] 0.018
Number of positive node 1.086 [1.030-1.155] 0.002
SBR grade 2 (ref. SBR1) 1.945 [0.551-6.871] 0.302
SBR grade 3 (ref. SBR1) 2.349 [0.628-8.794] 0.205
Estrogen receptor (negative) 1.527 [0.658-3.543] 0.325
Progesterone receptor (negative) 1.424 [0.6593-3.102] 0.374
CCR6+ tumor cells 1.929 [0.986-3.772] 0.055
CCL19+ DC 2.277 [1.141-3.772] 0.020
Overall Survival
Variable Hazard Ratio 95% CI p value
Tumor size (mm) 1.027 [1.006-1.049] 0.012
Number of positive node 1.118 [1.066-1.173] < 0.001
SBR grade 2 (ref. SBR1) 1.534 [0.549-4.287] 0.415
SBR grade 3 (ref. SBR1) 1.931 [0.666-5.605] 0.226
Progesterone receptor (negative) 1.419 [0.751-2.678] 0.281
CCR6+ tumor cells 1.205 [0.638-2.277] 0.565
CCL19+ DC 1.717 [0.916-3.219] 0.092
  1. SBR: Scarff-Bloom-Richardson grade; ref.: reference for analysis; CCR6+: CCR6-positive; CCR19+ DC: CCR19-positive dendritic cells.